Skip to main content
    C

    Creative Medical Technology Holdings Inc (CELZ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.52
    -0.01 (-1.51%)

    Market Cap: $4.01M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Creative Medical Technology Holdings Inc (CELZ) Earnings: Report Dates and Results

    Updated Nov 6, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Creative Medical Technology Holdings (CELZ) is expected to report earnings on Mar 18, 2027. In the quarter ended Sep 30, 2026, Creative Medical Technology Holdings reported EPS of -$0.40, below the -$0.24 estimate. It beat the EPS estimate in 2 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    42%(8/19)
    Avg Surprise
    -12.43%

    Upcoming Estimates

    Reports Mar 18, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.24
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts
    Reports May 6, 2027 (est.)Period ending Mar 31, 2027
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    0 analysts

    Next Report

    CELZ has an expected report date of Mar 18, 2027.

    Earnings History

    Of the 19 quarters below that had an estimate, CELZ beat 8, missed 9 and matched 2. The widest gap in the table came in the quarter ended Dec 31, 2025, when EPS landed 116.22% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.40-$0.24-$0.24 - -$0.24-66.67%MissN/A10 up, 1 downNov 6, 2026N/A
    Jun 30, 2026-$0.41-$0.39-$0.39 - -$0.39-5.13%MissN/A10 up, 0 downAug 7, 2026N/A
    Mar 31, 2026-$0.38-$0.39-$0.39 - -$0.39+2.56%BeatN/A10 up, 0 downMay 8, 2026N/A
    Dec 31, 2025-$0.80-$0.37-$0.37 - -$0.37-116.22%MissN/A10 up, 1 downMar 20, 2026$3000
    Sep 30, 2025-$0.48-$0.48N/A0.00%In lineN/A10 up, 1 downNov 7, 2025N/A
    Jun 30, 2025-$0.48-$0.63-$0.63 - -$0.63+23.81%BeatN/A10 up, 1 downAug 8, 2025N/A
    Mar 31, 2025-$0.83-$0.52-$0.52 - -$0.52-59.62%MissN/A11 up, 0 downMay 9, 2025$3000
    Dec 31, 2024-$1.12-$0.63-$0.63 - -$0.63-77.78%MissN/A11 up, 0 downMar 14, 2025$3000
    Sep 30, 2024-$0.75-$0.85N/A+11.76%BeatN/AN/A0 up, 0 downNov 8, 2024N/A
    Jun 30, 2024-$1.11-$0.84-$0.84 - -$0.84-32.14%MissN/A10 up, 0 downAug 9, 2024$8000
    Mar 31, 2024-$0.73-$1.15-$1.15 - -$1.15+36.52%BeatN/A10 up, 0 downMay 10, 2024N/A
    Dec 31, 2023-$1.19-$1.13-$1.13 - -$1.13-5.31%MissN/A10 up, 0 downMar 22, 2024$3000
    Sep 30, 2023-$1.02-$0.86-$0.86 - -$0.86-18.60%MissN/A10 up, 0 downNov 14, 2023$6000
    Jun 30, 2023-$0.78-$0.83-$0.83 - -$0.83+6.02%BeatN/A10 up, 0 downAug 11, 2023N/A
    Mar 31, 2023-$0.70-$1.00-$1.00 - -$1.00+30.00%BeatN/A10 up, 0 downMay 12, 2023N/A
    Dec 31, 2022-$0.07-$0.07N/A0.00%In lineN/A10 up, 0 downMar 31, 2023$18600
    Sep 30, 2022-$0.70-$1.30-$1.30 - -$1.30+46.15%BeatN/A10 up, 0 downNov 10, 2022$55000
    Jun 30, 2022-$2.00-$1.50-$1.50 - -$1.50-33.33%MissN/A10 up, 0 downAug 12, 2022N/A
    Mar 31, 2022-$1.80-$2.30N/A+21.74%Beat-116.1%10 up, 0 downMay 13, 2022$15000
    Dec 31, 2021-$4.16-$0.23-$0.23 - -$0.23N/AN/AN/A10 up, 0 downMar 30, 2022$67754
    Sep 30, 2021-$0.75N/AN/AN/AN/A-635.7%N/AN/ADec 6, 2021$10000
    Jun 30, 2021-$1.25N/AN/AN/AN/A-905.4%N/AN/AAug 16, 2021$10000
    Mar 31, 2021$11.18N/AN/AN/AN/AN/AN/AN/AMay 17, 2021N/A
    Dec 31, 2020-$31.93N/AN/AN/AN/A-1407.8%N/AN/AMar 17, 2021$17500
    Sep 30, 2020$0.14N/AN/AN/AN/AN/AN/AN/ANov 13, 2020$77000
    Jun 30, 2020$0.16N/AN/AN/AN/AN/AN/AN/AAug 14, 2020$27900
    Mar 31, 2020-$5.45N/AN/AN/AN/AN/AN/AN/AApr 6, 2020$42100
    Dec 31, 2019$2.44N/AN/AN/AN/AN/AN/AN/AMar 31, 2020N/A
    Sep 30, 2019-$146.51N/AN/AN/AN/A-179.4%N/AN/ANov 14, 2019$57500
    Jun 30, 2019-$119.36N/AN/AN/AN/AN/AN/AN/AAug 13, 2019$61600
    Mar 31, 2019-$6.22N/AN/AN/AN/AN/AN/AN/AMay 20, 2019$50800
    Dec 31, 2018-$61.93N/AN/AN/AN/AN/AN/AN/AMar 31, 2019$57600
    Sep 30, 2018$184.54N/AN/AN/AN/AN/AN/AN/ANov 14, 2018$52400
    Jun 30, 2018-$0.32N/AN/AN/AN/AN/AN/AN/AAug 2, 2018$4800
    Mar 31, 2018-$1.55N/AN/AN/AN/AN/AN/AN/AJun 30, 2018$9600
    Dec 31, 2017-$6.05N/AN/AN/AN/AN/AN/AN/AMar 29, 2018$4800
    Sep 30, 2017-$2.06N/AN/AN/AN/AN/AN/AN/ANov 13, 2017N/A
    Jun 30, 2017-$0.07N/AN/AN/AN/AN/AN/AN/AAug 14, 2017N/A
    Mar 31, 2017-$1.25N/AN/AN/AN/AN/AN/AN/AMay 10, 2017N/A
    Dec 31, 2016-$0.35N/AN/AN/AN/AN/AN/AN/AFeb 13, 2017N/A
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$2.59, after -$3.71 the year before. It was -$1.28 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$2.59N/A
    Dec 31, 2024-$3.71N/A
    Dec 31, 2023-$3.69N/A
    Dec 31, 2022-$4.57-191.0%
    Dec 31, 2021$5.02N/A
    Dec 31, 2020-$37.08N/A
    Dec 31, 2019-$269.64-323.3%
    Dec 31, 2018$120.75N/A
    Dec 31, 2017-$9.43N/A
    Dec 31, 2016-$1.28N/A

    Frequently Asked Questions About CELZ

    When is Creative Medical Technology Holdings's next earnings date?

    Creative Medical Technology Holdings's next earnings report is expected for Mar 18, 2027.

    Did CELZ beat earnings estimates last quarter?

    No. Creative Medical Technology Holdings reported EPS of -$0.40 for the quarter ended Sep 30, 2026, below the -$0.24 estimate by 66.67%.

    What EPS do analysts expect from CELZ next quarter?

    The consensus EPS estimate for Creative Medical Technology Holdings for the quarter ending Dec 31, 2026 is -$0.24 from 3 analysts.

    How often does CELZ beat earnings estimates?

    Creative Medical Technology Holdings beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -37.38%.